RLI (RLI) posted a net profit margin of 19%, down from last year's 23.8%, with earnings per share having climbed by an average of 8.3% annually over the past five years. However, the outlook calls for ...

Year-to-date total sales growth of 12.1% at CER1, or 9.6% as reported, driven by all three therapeutic areas and including ...